Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.

Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K.

Int J Radiat Biol. 2019 Dec;95(12):1708-1717. doi: 10.1080/09553002.2019.1666214. Epub 2019 Sep 23.

PMID:
31545117
2.

Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

Masunaga S, Sakurai Y, Tanaka H, Suzuki M, Liu Y, Kondo N, Maruhashi A, Kinashi Y, Ono K.

Br J Radiol. 2012 Mar;85(1011):249-58. doi: 10.1259/bjr/20974899.

3.

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis.

Masunaga SI, Sakurai Y, Tano K, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A, Ono K.

Exp Ther Med. 2014 Jul;8(1):291-301. Epub 2014 May 8.

4.

Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential.

Masunaga S, Liu Y, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K.

Int J Hyperthermia. 2012;28(7):636-44. doi: 10.3109/02656736.2012.714517. Epub 2012 Sep 4.

PMID:
22946564
5.

Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.

Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H.

Jpn J Cancer Res. 2001 Sep;92(9):996-1007.

6.

The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.

Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.

Int J Hyperthermia. 2006 Jun;22(4):287-99.

PMID:
16754350
7.

Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.

Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):920-7.

PMID:
15465210
8.

Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.

Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Suzuki M, Nagata K, Nagasawa H, Uto Y, Hori H.

J Cancer Res Clin Oncol. 2003 Jan;129(1):21-8. Epub 2003 Jan 11.

PMID:
12618897
9.

The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.

Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K.

Int J Hyperthermia. 2005 Jun;21(4):305-18.

PMID:
16019857
10.

Applicability of combination with tirapazamine in boron neutron capture therapy.

Masunaga S, Ono K, Sakurai Y, Hori H, Kobayashi T, Takagaki M, Suzuki M, Kinashi Y, Akaboshi M.

Jpn J Cancer Res. 1998 Jul;89(7):768-74.

11.

Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.

Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H.

Cancer Sci. 2003 Jan;94(1):125-33.

12.

Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.

Masunaga S, Matsumoto Y, Hirayama R, Kashino G, Tanaka H, Suzuki M, Kinashi Y, Liu Y, Ando K, Ono K.

Clin Exp Metastasis. 2009;26(7):693-700. doi: 10.1007/s10585-009-9268-5. Epub 2009 May 23.

PMID:
19466568
13.

Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.

Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M.

Br J Radiol. 1997 Apr;70(832):391-8.

PMID:
9166076
14.

Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.

Masunaga S, Matsumoto Y, Kashino G, Hirayama R, Liu Y, Tanaka H, Sakurai Y, Suzuki M, Kinashi Y, Maruhashi A, Ono K.

Br J Radiol. 2010 Sep;83(993):776-84. doi: 10.1259/bjr/57015642.

15.

Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.

Masunaga SI, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Tano K, Maruhashi A, Ono K.

World J Oncol. 2013 Feb;4(1):26-36. doi: 10.4021/wjon640w. Epub 2013 Mar 6.

16.

Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Masunaga S, Nagasawa H, Gotoh K, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.

Radiat Med. 2006 Feb;24(2):98-107.

PMID:
16715670
17.

Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.

Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):828-39.

PMID:
11697329
18.

Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.

Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.

Anticancer Res. 2004 Sep-Oct;24(5A):2975-83.

19.

Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.

Masunaga SI, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A, Ono K.

World J Oncol. 2014 Aug;5(4):155-165. doi: 10.14740/wjon855w. Epub 2014 Aug 25.

20.

Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.

Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):799-807.

PMID:
10837967

Supplemental Content

Support Center